Stifel remains optimistic on biotech into 2027, expecting renewed M&A, strong capital markets, and continued pharma demand to support the sector despite near-term macro and political headwinds, with market and transaction data provided in part by DealForma. Read it here
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive
